1887

Journal of General Virology header logo

Volume 74, Issue 9

Assessment of the antigenic structure of tick-borne encephalitis virus by the use of synthetic peptides Free

Abstract

The feasibility of using synthetic peptides for the identification of individual monoclonal antibody (MAb)-defined epitopes was assessed on the basis of a structural model of the tick-borne encephalitis (TBE) virus envelope glycoprotein E. For this purpose a series of 19 synthetic peptides was prepared, covering most of the E protein sequence. Each of the peptides was tested by ELISA for reactivity with 19 protein E-specific MAbs raised against TBE virus strain Neudoerfl. Specific reactivity was observed with three MAbs and two peptides (representing amino acids 1 to 22 and 221 to 240, respectively), thus providing new information on the location of the corresponding epitopes. Specificity was confirmed in a competition ELISA by the ability of the peptides to block MAb binding to TBE virus antigen. However, in contrast to the other MAbs, these peptide-reactive MAbs were not blocked by native virus particles in the competition ELISa, indicating that they do not recognize the native conformation of the E protein. These three MAbs also showed increased reactivity with denatured forms of the virus in a dot blot assay. Additionally, they reacted only in ELISA systems in which the virus was directly coated to the solid phase and thereby presumably partially denatured, but not when a capture antibody was used, which preserves the native antigen conformation. We have thus identified two classes of MAbs, those which recognize the native form and those which recognize the denatured form of protein E. The latter may be useful for the analysis of sites probably involved in protein folding and oligomerization.

  • Received:
  • Accepted:
  • Published Online:
© Society for General Microbiology 1993
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-9-2031
1993-09-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/9/JV0740092031.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-9-2031&mimeType=html&fmt=ahah

References

  1. Aaskov JG, Geysen HM, Mason TJ. 1989; Serological defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409).. Archives of Virology 105:209–221
     [Google Scholar]
  2. Bjorling E, Broliden K, Bernardi D, Utter G, Thorstensson R, Chiodi F, Norrby E. 1991; Hyperimmune sera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity.. Proceedings of the National Academy of Sciences, U.S.A. 88:6082–6086
     [Google Scholar]
  3. Friguet B, Djavadi-Ohaniance L, Goldberg ME. 1984; Some monoclonal antibodies raised with a native protein bind preferentially to the denatured antigen.. Molecular Immunology 21:673–677
     [Google Scholar]
  4. Geysen HM, Meloen RH, Barteling SJ. 1984; Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.. Proceedings of the National Academy of Sciences, U.S.A. 81:3998–1002
     [Google Scholar]
  5. Guirakhoo F, Heinz FX, Kunz C. 1989; Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH.. Virology 169:90–99
     [Google Scholar]
  6. Heinz FX, Berger R, Tuma W, Kunz C. 1983; A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies.. Virology 126:525–537
     [Google Scholar]
  7. Henrickson KJ, Kingsbury DW, van Wyke Coelingh KL, Naeve CW, Portner A. 1991; Neutralizing epitopes of human parainfluenza virus type 3 are conformational and cannot be imitated by synthetic peptides.. Vaccine 9:243–249
     [Google Scholar]
  8. Hollander Z, Katchalski-Katzir E. 1986; Use of monoclonal antibodies to detect conformational alterations in lactate dehydrogenase isoenzyme 5 on heat denaturation and on absorption to polystyrene plates.. Molecular Immunology 23:927–933
     [Google Scholar]
  9. Houghten RA. 1985; General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.. Proceedings of the National Academy of Sciences, U.S.A. 82:5131–5135
     [Google Scholar]
  10. Houghten RA, Bray MK, de Graw ST, Kirby CJ. 1986; Simplified procedure for carrying out simultaneous multiple hydrogen fluoride cleavages of protected peptide resins.. International Journal of Peptide and Protein Research 27:675–683
     [Google Scholar]
  11. Innis BL, Thirawuth V, Hemachudha C. 1989; Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus.. American Journal of Tropical Medicine and Hygiene 40:676–687
     [Google Scholar]
  12. Javaherian K, Langlois AJ, McDanal C, Ross KL, Eckler LI, Jellis CL, Profy AT, Rusche JR, Bolognesi DP, Putney SD, Matthews TJ. 1989; Principal neutralization domain of the human immunodeficiency virus type 1 envelope protein.. Proceedings of the National Academy of Sciences, U.S.A. 86:6768–6772
     [Google Scholar]
  13. Jemmerson R. 1987; Antigenicity and native structure of globular proteins: low frequency of peptide reactive antibodies. Proceedings of the National Academy of Sciences, U.S.A. 84:9180–9184
     [Google Scholar]
  14. Jemmerson R, Blankenfeld R. 1989; Affinity consideration in the design of synthetic vaccines intended to elicit antibodies.. Molecular Immunology 26:301–307
     [Google Scholar]
  15. Mandl CW, Guirakhoo F, Holzmann H, Heinz FX, Kunz C. 1989; Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model.. Journal of Virology 63:564–571
     [Google Scholar]
  16. Markoff LJ, Bray M, Lai CJ, Chanock RM, Eckels K, Summers P, Gentry MK, Houghten RA, Lerner RA. 1988; Antigenic analysis of the dengue virus envelope glycoprotein using synthetic peptides.. In Vaccines 88 pp 161–165Edited by Ginsberg H., Brown F., Lerner R. A., Chanock R. M. New York: Cold Spring Harbor Laboratory;
     [Google Scholar]
  17. Nestorowicz A, Tregear GW, Southwell CN, Martyn J, Murray JM, White DO, Jackson DC. 1985; Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites.. Molecular Immunology 22:145–154
     [Google Scholar]
  18. Norrby E, Mufson MA, Alexander H, Houghten RA, Lerner RA. 1987; Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus.. Proceedings of the National Academy of Sciences, U.S.A. 84:6572–6576
     [Google Scholar]
  19. Pfaff E, Thiel HJ, Beck E, Strohmaier K, Schaller H. 1988; Analysis of neutralizing epitopes on foot-and-mouth disease virus.. Journal of Virology 62:2033–2040
     [Google Scholar]
  20. Roehrig JT, Hunt AR, Johnson AJ, Hawkes RA. 1989; Synthetic peptides derived from the deduced amino acid sequence of the E glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody.. Virology 171:49–60
     [Google Scholar]
  21. Roehrig JT, Johnson AJ, Hunt AR, Bolin RA, Chu MC. 1990; Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation.. Virology 177:668–675
     [Google Scholar]
  22. Scibienski RJ. 1973; Denaturation of lysozyme by Freund’s complete adjuvant. Journal of Immunology 111:114–120
     [Google Scholar]
  23. Snijders A, Benaissa-Trouw BJ, Oosterlaken TAM, Puijk WC, Posthumus WPA, Meloen RH, Boere WAM, Oosting JD, Kraaijeveld CA, Snippe H. 1991; Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine.. Journal of General Virology 72:557–565
     [Google Scholar]
  24. Tam JP, Heath WF, Merrifield RB. 1983; SN2 deprotection of synthetic peptides with a low concentration of HF in dimethyl sulfide: evidence and application in peptide synthesis.. Journal of the American Chemical Society 105:6442–6455
     [Google Scholar]
  25. Warren RQ, Anderson SA, Nkya WMMM, Shao JF, Hendrix CW, Melcher GP, Redfield RR, Kennedy RC. 1992; Examination of sera from human immunodeficiency virus type 1 (HlV-l)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gpl20 and for in vitro neutralizing activity.. Journal of Virology 66:5210–5215
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-9-2031
Loading
Assessment of the antigenic structure of tick-borne encephalitis virus by the use of synthetic peptides
J. Gen. Virol. 74, 2031 (1993); https://doi.org/10.1099/0022-1317-74-9-2031
/content/journal/jgv/10.1099/0022-1317-74-9-2031
/content/journal/jgv/10.1099/0022-1317-74-9-2031
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error